Streetbeat News

Stock Prices

CE

Over the past 3 months, 6 analysts have published their opinion on Celanese (NYSE:CE) stock. The company has an average price target of $140.17, up by 1.57% from the previous average price target of $138.00. The majority of the analysts are somewhat bullish on the stock.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:00 pm

EXPD

In the last quarter, Expeditors Intl (NASDAQ:EXPD) received one indifferent and four somewhat bearish ratings from analysts. The company's average 12-month price target is $99.4, with a high of $110.00 and a low of $85.00. This average price target has increased by 0.66% over the past month.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:00 pm

NMRA

Neumora Therapeutics (NASDAQ:NMRA) has received positive analyst ratings in the last quarter, with 6 bullish and 3 somewhat bullish ratings. The average 12-month price target for the company has increased by 3.95% to $21.83.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:00 pm

CG

Over the past quarter, Carlyle Group (NASDAQ:CG) has received 1 bullish, 4 somewhat bullish, and 1 indifferent rating from analysts. The average 12-month price target for the company has increased by 4.16% to $43.33, with a high of $53.00 and a low of $34.00.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:00 pm

CHRS

Coherus BioSciences (NASDAQ:CHRS) has received positive analyst ratings in the last quarter, with 3 bullish and 1 somewhat bullish ratings. The average 12-month price target for the company is $15.0, which has increased by 7.14% over the past month.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:00 pm

EIS

SPY

According to Syrian state media, Israel has conducted an air strike on military sites in southern Syria. The potential impact on US-listed ETFs EIS (iShares MSCI Israel ETF) and SPY (SPDR S&P 500 ETF Trust) is uncertain.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 8:53 pm

BLK

GBTC

The approval window for all pending Spot Bitcoin ETFs opens tomorrow and will last for at least eight days. Bloomberg’s ETF analyst James Seyffart and BI Senior ETF analyst Eric Balchunas suggest a 90% probability of approval by Jan. 10, 2024. The 12 Spot Bitcoin ETF applications are from Grayscale, ARK 21Shares, BlackRock, Bitwise, VanEck, Wisdomtree, Invesco & Galaxy, Fidelity, Valkyrie, Global X, Hashdex, and Franklin Templeton. BlackRock's approval could bring $200 billion to Bitcoin and push BTC price to $330,000.

Portfolio Pulse from Khyathi Dalal

November 08, 2023 | 8:51 pm

UBER

Analysts from Truist Securities, Needham, Mizuho, Morgan Stanley, and Roth MKM have maintained or reiterated their positive ratings on Uber Technologies Inc (NYSE:UBER), despite mixed Q4 guidance. The analysts highlighted Uber's strong momentum in Mobility and Delivery, record high EBITDA margins, and improving operational efficiencies as key to its long-term growth. However, they also noted potential challenges such as competition with Lyft, geopolitical uncertainty, and consumer spending trends.

Portfolio Pulse from Anusuya Lahiri

November 08, 2023 | 8:50 pm

ESTA

Establishment Labs (ESTA) has secured approval from China's National Medical Products Administration (NMPA) for its Motiva Implants. This news has been positively received by analysts from BTIG and JP Morgan, leading to increased trading volume of ESTA shares.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 8:46 pm

BMBL

Susquehanna analyst Shyam Patil maintains a positive outlook on Bumble (NASDAQ:BMBL), but has lowered the price target from $25 to $17.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 8:41 pm